STOCK TITAN

HUTCHMED (HCM) director Daniel Tan submits initial Form 3 filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

HUTCHMED (China) Ltd director Daniel Shao Weng Tan filed an initial insider ownership report on Form 3. The filing lists him as a director of the company and does not report any insider buy, sell, acquisition, or disposition transactions at this time.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Tan Daniel Shao Weng

(Last) (First) (Middle)
C/O 48TH FLOOR, CHEUNG KONG CENTER,
2 QUEEN'S ROAD CENTRAL

(Street)
HONG KONG K3 00000

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/10/2026
3. Issuer Name and Ticker or Trading Symbol
HUTCHMED (China) Ltd [ HCM ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
No securities are beneficially owned.
/s/ TAN Daniel Shao Weng 03/10/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who is the reporting person in the HUTCHMED (HCM) Form 3 filing?

The reporting person is Daniel Shao Weng Tan, identified as a director of HUTCHMED (China) Ltd. The Form 3 associates him with the issuer but shows no insider buy, sell, acquire, or dispose transactions in the provided data.

What role does Daniel Shao Weng Tan hold at HUTCHMED (HCM)?

Daniel Shao Weng Tan is listed as a director of HUTCHMED (China) Ltd. The Form 3 data shows the director box checked, while the officer, ten percent owner, and other roles are not marked, indicating his primary relationship is as a board director.

Does the HUTCHMED (HCM) Form 3 show any insider share transactions?

The Form 3 data provided shows no insider share transactions. Buy, sell, acquire, dispose, and other transaction counts are all zero, and there are no reported shares bought or sold, indicating only an initial reporting relationship without trading activity.

What does the transaction summary indicate in this HUTCHMED (HCM) Form 3?

The transaction summary indicates zero buys, zero sells, and zero acquisitions or dispositions, with net buy/sell shares at zero and direction labeled neutral. This reflects that no reportable transactions are included with this initial insider ownership filing.

Are there any footnote-based ownership clarifications in this HUTCHMED Form 3?

The Form 3 structure includes a footnotes section, but the provided data only shows a null entry. There are no detailed footnote explanations regarding voting power, investment authority, or indirect ownership arrangements visible in the supplied content.
Hutchmed (China) Limited

NASDAQ:HCM

View HCM Stock Overview

HCM Rankings

HCM Latest News

HCM Latest SEC Filings

HCM Stock Data

2.37B
174.47M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Hong Kong
CAMBRIDGE